399
Participants
Start Date
November 11, 2016
Primary Completion Date
April 22, 2019
Study Completion Date
May 17, 2019
Sotagliflozin (SAR439954)
"Pharmaceutical form: tablet;~Route of administration: oral"
Placebo
"Pharmaceutical form: tablet;~Route of administration: oral"
Investigational Site Number 4841003, Cd. México, México
Investigational Site Number 4841007, México
Investigational Site Number 8401041, Levittown
Investigational Site Number 4841006, Aguascalientes
Investigational Site Number 4841010, Aguascalientes
Investigational Site Number 8401012, Greensboro
Investigational Site Number 8401042, Fayetteville
Investigational Site Number 8401051, Anderson
Investigational Site Number 8401002, Greer
Investigational Site Number 8401033, Atlanta
Investigational Site Number 4841004, Chihuahua City
Investigational Site Number 8401014, Daytona Beach
Investigational Site Number 8401053, Orlando
Investigational Site Number 8401007, Hialeah
Investigational Site Number 8401046, Homestead
Investigational Site Number 8401018, Miami
Investigational Site Number 8401008, Miami
Investigational Site Number 8401040, Clearwater
Investigational Site Number 4841005, Durango, Durango
Investigational Site Number 8401024, Bradenton
Investigational Site Number 8401062, Palm Harbor
Investigational Site Number 8401003, Marion
Investigational Site Number 8401048, Akron
Investigational Site Number 4841009, Guadalajara
Investigational Site Number 8401052, Newton
Investigational Site Number 8401016, West Des Moines
Investigational Site Number 8401044, Chicago
Investigational Site Number 4841008, Monterrey
Investigational Site Number 4841002, Monterrey, Nuevo León
Investigational Site Number 8401038, Lake Charles
Investigational Site Number 8401005, Fort Worth
Investigational Site Number 8401059, North Richland Hills
Investigational Site Number 8401019, Houston
Investigational Site Number 8401050, Houston
Investigational Site Number 8401037, Katy
Investigational Site Number 8401023, Sugar Land
Investigational Site Number 8401055, Schertz
Investigational Site Number 8401004, San Antonio
Investigational Site Number 8401054, San Antonio
Investigational Site Number 8401001, San Antonio
Investigational Site Number 8401043, McAllen
Investigational Site Number 8401031, Denver
Investigational Site Number 4841001, Culiacán
Investigational Site Number 8401060, Northglenn
Investigational Site Number 8401049, Tucson
Investigational Site Number 8401026, Tucson
Investigational Site Number 8401063, Los Angeles
Investigational Site Number 8401011, Los Angeles
Investigational Site Number 8401017, Huntington Park
Investigational Site Number 8401039, Norwalk
Investigational Site Number 8401029, Hawaiian Gardens
Investigational Site Number 8401056, Long Beach
Investigational Site Number 8401013, Long Beach
Investigational Site Number 8401057, Canoga Park
Investigational Site Number 8401015, Van Nuys
Investigational Site Number 8401035, San Dimas
Investigational Site Number 8401022, Montclair
Investigational Site Number 8401025, Tustin
Investigational Site Number 8401028, Anaheim
Investigational Site Number 8401020, Corvallis
Investigational Site Number 8401006, Eugene
Investigational Site Number 8401058, Garden Grove
Investigational Site Number 8401061, West Palm Beach
Investigational Site Number 8401034, Wichita
Investigational Site Number 8401032, Chesapeake
Investigational Site Number 8401010, Suffolk
Investigational Site Number 1241002, Sherbrooke
Investigational Site Number 1241005, Toronto
Investigational Site Number 1241001, Toronto
Investigational Site Number 1241006, Vancouver
Lead Sponsor
Collaborators (1)
Sanofi
INDUSTRY
Lexicon Pharmaceuticals
INDUSTRY